420 with CNW – First Cannabis Restaurant in the UK Set to Open

A restaurant that will offer meals infused with cannabis is due to open in the UK on December 1. The vegetarian and vegan dishes served at this Brighton restaurant will be infused with CBD compounds extracted from the cannabis plant.

The Canna Kitchen aims at changing the way people look at marijuana. The range of vegan and vegetarian dishes infused with CBD will show that marijuana isn’t just for recreational use. The restaurant wants to show the different fragrances, flavors, therapeutic and nutritional benefits inherent in the cannabis plant.

However, a client will first place an order to have his or her meal infused with CBD. This means that vegans or vegetarians who aren’t interested in sampling the cannabis-infused offerings can still dine at the restaurant.

It should be remembered that cannabis is a restricted substance in the UK and only became legal for medicinal use on November 1 this year. Those found in possession of cannabis may be jailed for five years while those found distributing it can be imprisoned for 14-years or face huge fines.

So, how will “The Canna Kitchen” operate legally? The laws in the UK permit the use of the non-psychoactive compounds in the marijuana plant. This means that the restaurant can freely use CBD and other non-psychoactive cannabinoids in its dishes without contravening any existing laws.

Cannabis is still highly restricted across the world. Only a few countries, including Canada and Uruguay, have legalized recreational marijuana. Ten states in the U.S. have permitted recreational marijuana and there are campaigns to end prohibition in more states.

Medical marijuana has fared better across the world with more countries making it legal nearly every month. This growing interest in cannabis has prompted many huge multinationals like Coca Cola to explore avenues of making cannabis-infused drinks so that the companies cash in on the wave of popularity that has engulfed marijuana. That wave of popularity is projected to be worth approximately $75 billion by 2030. That is such a huge magnet to anyone looking for a money-making opportunity.

Against that backdrop, the idea behind The Canna Kitchen is likely to trigger other entrepreneurial ventures all geared at bringing more cannabis-infused products to the market. After all, marijuana is now the new “cool” and even politicians are falling over each other to show support for legalization.

Existing industry players like GreenBox POS, LLC (OTC: GRBX) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) welcome the initiative taken by the brains behind The Canna Kitchen. Such efforts will be remembered when the cannabis industry becomes fully established around the world.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Mexico Could Soon Legalize Recreational Marijuana

As the U.S. is still grappling with how to deal with the legalization of recreational cannabis in Canada, its challenges are likely to increase if what is happening in its other neighbor’s legal system results in the legalization of recreational pot.

Last week, the Supreme Court in Mexico made two rulings to the effect that it was unconstitutional to prevent adults from consuming marijuana if they so wished. The cases that resulted in those rulings had been filed by individuals who were challenging the constitutionality of stopping them from consuming recreational marijuana.

The court observed that adults have the right to choose whether or not to consume cannabis, so it is improper to deny them that right.

Between 2015 and 2017, three similar rulings were made by the Supreme Court, which is the highest court in Mexico.

The court ruling also indicated that the right isn’t absolute, so the state still has the mandate to restrict the exercise of that right. Individuals must therefore argue their case before the judicial system in order to get express permission to consume a restricted substance.

However, the previous three rulings on the subject now bring the total number of similar rulings by the Supreme Court to five. Under Mexican law, any subject that accumulates five similar rulings in the Supreme Court sets a precedent which all the other courts must follow.

In effect, that means that no court will be able to object to anyone who applies to start consuming recreational marijuana. The bigger implication is that the way has been cleared for recreational marijuana to be legalized since the legislators cannot leave such an issue unregulated now that the Supreme Court has made five rulings in favor of the complainants who challenged the constitutionality of the criminalization of adult-use marijuana.

A similar scenario played out over same-sex marriages. The Supreme Court made five rulings allowing gay couples to wed so it was no longer possible for such a marriage to be blocked through judicial means. However, no law has been passed as yet to regulate same-sex marriages.

Recreational marijuana is different in that the way may have been opened for thousands or even millions of people to apply to the courts of law in order to be allowed to consume recreational marijuana. Such a possibility can choke the legal system, not to mention the public health and safety concerns that may arise when such a large number of people is allowed to consume recreational marijuana in the absence of any laws to regulate such consumption other than the requirement that the individuals don’t sell the substance.

It is therefore likely that the country’s legislative body (congress) will soon draft a law to regulate recreational marijuana. Medical marijuana became legal in 2017, so it isn’t as though drafting laws on marijuana will be a new thing for the legislators.

It remains to be seen how the U.S. will respond to the legalization of recreational marijuana by all its neighbors. Already, the government has been fighting the smuggling of marijuana from Mexico. Companies with interests in the marijuana industry, such as GreenBox POS, LLC (OTC: GRBX) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) may be pleased that additional markets will soon open and increase their opportunities.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Three Studies Give Further Proof of Marijuana’s Effect on Opioid Crisis

A trio of scientific studies has provided further proof that legalizing marijuana can reduce the opioid crisis facing America. At first glance, it may appear that legalizing marijuana will increase opioid overdoses. However, the studies conducted gathered data that proves otherwise.

  1. Arthritis Sufferers Who Underwent Reconstructive Surgery Used Fewer Opioids if Cannabis Was Accessible

A new study whose findings appeared in the Journal of Orthopedic Proceedings analyzed the toxicological tests of more than 520 patients. The tests in question were conducted between 2012 and 2017.

The researchers found that patients who used cannabis before undergoing reconstructive surgery to repair joints affected by arthritis increased from just 9 percent to 15 percent during the period being studied. At the same time, the prevalence of opioid use dropped to 17 percent from 24 percent.

There appears to be a correlation between the increase in access to marijuana and a reduction in the use of opioids.

  1. States with Legal Marijuana Have Fewer Opioid Prescriptions

Another group of researchers gathered data on more than 1.3 billion prescriptions of opioids. Those prescriptions were spread over several years from 2011 to 2018. The researchers analyzed that data in order to establish whether there was a connected between marijuana laws and the rate at which opioids are prescribed.

The investigators found that in states where marijuana was fully legal (for recreational and medical purposes) prescriptions for opioids, especially morphine, reduced by 6.9 percent every year.

The study found that in the states where only medical marijuana was legal, morphine prescriptions reduced by 6.1 percent each year.

The researchers concluded that access to cannabis caused the rate at which morphine is prescribed to reduce by a percentage which is statistically significant.

  1. Opioid Abuse Decreased as Cannabis Use Went Up

The federally funded National Survey on Drug Use and Health conducted in 2017 compared the level of opioid misuse among Americans in 2016 and 2017. The researchers found that about 11.4 million Americans abused opioids in 2017 yet the number was higher (11.8 million) the year before.

The same survey found that the number of Americans who used marijuana in 2016 was 24 million while those who used cannabis the next year increased to 26 million. This increase in cannabis use could possibly explain why opioid abuse reduced in the years under scrutiny.

As you can see, studies conducted by private entities and those funded by states or the federal government all seem to point to the strong possibility of marijuana having the key to the opioid epidemic the country is facing. Such findings are good news to industry players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Canada Leads International Cannabis Boom — and It’s Not About Smoking

CannabisNewsWire Editorial Coverage: Legal changes in Canada are creating an ideal base for cannabis companies, which are shifting their focus away from smoking.

  • As the first G20 nation to make recreational cannabis legal, Canada is creating an opportunity for its cannabis companies to become global leaders.
  • Analysis shows that the global cannabis market is larger than expected — and set to keep growing.
  • Many new consumers prefer not to smoke their cannabis, leading to a shift towards cannabis-derived food and drinks.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed patented technology that helps make cannabis available to nonsmokers; the company’s innovative development methods make cannabis’ active chemicals more palatable and more effective in food and drink. Companies such as Tilray, Inc. (NASDAQ: TLRY) are expanding their production to cater to this growing market, resulting in rising share values. GW Pharmaceuticals Plc (NASDAQ: GWPH) has leveraged its position in the market to raise extra financing through a $345 million public offering.  Aurora Cannabis, Inc. (OTC: ACBFF) (TSX: ACB) has been focusing on ensuring access to a broad market, setting up supply agreements across Canada. Meanwhile, other companies are evaluating international growth opportunities, with Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) having established…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – UK Doctors to Start Prescribing Cannabis in November

Doctors in the UK (Wales, Scotland and England) will soon start prescribing cannabis for their patients who have conditions that can be improved by this substance.

This announcement was made by the UK Home Secretary, Sajid Javid. He stated that cannabis would see its status changed from a schedule 1 substance (substances with no therapeutic value but having a high likelihood of being abused) to a schedule 2 controlled substance.

That change would allow doctors to prescribe cannabis-products for those patients who would benefit from such derivatives (CBD oil, for example).

However, cannabis would still be controlled since its new status would still regard it as something that has a high potential for being abused.

The Home Secretary said as much when he reiterated that adult use of cannabis would not be accepted and no patient would be allowed to smoke cannabis as a way of treating his or her condition.

The new regulations that will amend the Misuse of Drugs Regulations 2001 will come into force on November 1.

The amendments come hot on the heels of prominent cases in which several kids were denied the right to use cannabis oil as a way of controlling their epileptic seizures. Those cases were controversial because cannabis oil had been found to be beneficial for people suffering from refractory epilepsy.

The new regulations will permit three avenues through which a person can consume cannabis-based products. The first way is when the patient gets a prescription from a doctor to get a medical product made from cannabis.

The second way through which one can consume a cannabis product is when such a product is being used in an investigational program (clinical study) into which the user has been enrolled.

The third and final way through which one can consume a cannabis product is when such a product has been approved for sale by the relevant regulators. This category includes medicinal cannabis products that have been approved as over the counter products for which a prescription isn’t required.

The regulatory changes by the UK government comes at a time when an expert committee of the World Health Organization is set to meet in November to review the classification of marijuana as a schedule 1 controlled substance. That meeting also comes at a time when Canada has just made history as the first G8 member state to legalize recreational marijuana.

These positive actions in the cannabis industry are pieces of good news to Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) who are convinced about the benefits that this product can bring.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBD Exploding into Mainstream Wellness Products

CannabisNewsWire Editorial Coverage: Bolstered by millennia of anecdotal evidence and ever-mounting scientific validation, cannabidiol (CBD) is rapidly being integrated into myriad mainstream consumer wellness products around the globe.

  • Global cannabis market expected to quadruple to over $63 billion by 2024
  • CBD oil market to grow at CAGR of 39.19 percent through 2021
  • CBD products exploding into a wide variety of product lines
  • Diversified, sales-driven companies expected to outpace standard growth curve

Humans have used hemp, a variety of Cannabis sativa and a primary source of CBD, for more than 10,000 years in food, textiles and medicine. The world is again recognizing the therapeutic benefits of hemp extracts, and consumers are embracing cannabis-based products at a breakneck pace. Consumer demand has triggered an explosion of product innovations that range from oils and edibles to pet products and infused beverages. Intent on staying at the vanguard of the upsurge in CBD-based wellness products, sales and marketing powerhouse Youngevity International, Inc. (NASDAQ: YGYI) (YGYI Profile) recently expanded its HempFX™ line with the launch of two new hemp-derived cannabidiol products. Others are entering the sector as well. Beer and spirits conglomerate Constellation Brands, Inc. (NYSE: STZ) just made the largest investment to date in the cannabis industry. AbbVie Inc. (NYSE: ABBV) was one of the first companies to enter the pharmaceutical cannabis space with Marinol, which is almost chemically identical to THC, the main component in marijuana. Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) offers DehydraTECH, a drug delivery platform that could be a game changer for several industries, including the recreational and medical cannabis markets. And Neptune Wellness Solutions, Inc. (NASDAQ: NEPT) recently received a Confirmation of Readiness letter from…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – American Cannabis Producers Fear Canadian Industry Dominance

Cannabis industry players in the U.S. are concerned that the stubborn insistence on prohibition by the federal government will give Canadian producers a chance to dominate the marijuana industry.

These sentiments were voiced by Derek Peterson, the CEO of marijuana firm Terra Tech based in California. He revealed that industry players in the U.S. are constrained by many factors which put a damper on their growth and activities.

First, cannabis cannot cross state lines since marijuana is still outlawed at the federal level. This restriction means that producers must operate at low capacity just for the market within the state where they are licensed to operate.

Secondly, the players in the marijuana industry cannot access funding from major banks since the banks fear federal repercussions resulting from doing business with an industry that is considered illegal. Marijuana companies therefore face funding challenges each time they want to expand or conduct expensive product research. In contrast, Canadian firms are trading publicly and amassing capital.

The third impediment is that Customs and Border Protection has vowed to deny entry to any marijuana industry investors. This has deterred some foreign nationals who may have wished to put their money in U.S. cannabis companies.

These shortcomings have given a chance to Canadian companies to spread their operations to the U.S. For example, Tilray was recently permitted to export marijuana extract capsules for use during a study on the impact of cannabis on essential tremor. This was after the researchers convinced the DEA that such products weren’t available locally.

Such inroads are likely to grow over time since Canada has had a head start due to the forward-looking regulatory framework that was passed in Canada upon the legalization of medical cannabis years back and the impending decriminalization of adult use of marijuana a few days from now.

Private firms were allowed to participate in the industry right from its legalization, and that private enterprise has permitted Canada to be a world leader in this young industry. In contrast, the U.S. has for long allowed only Mississippi University to hold the sole license for cannabis cultivation until states started decriminalizing marijuana and licensing their own producers.

The U.S. is therefore having to play catch up with Canada, but the federal prohibitionist stance still limits how quickly the domestic industry can grow since the players are fragmented and can only operate in small jurisdictions. The large U.S. market will only be exploited fully for rapid growth once cannabis is legalized at the federal level. That decriminalization will allow firms like Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to put all their energies in capturing the massive potential market across the nation.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector

CannabisNewsWire Editorial Coverage: Intangible assets such as patents increasingly dominate the global business landscape, especially in the pharmaceutical sector.

  • Intangible assets are estimated to be worth trillions of dollars in the United States alone.
  • These assets drive deals as companies acquire smaller patent holders.
  • In growing sectors such as cannabis, smaller companies are rushing to establish intangible assets ready for expected market growth.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) is one of the leaders in the world of cannabis, with applications made for more than 50 different patents and more to come. Tilray Inc. (NASDAQ: TLRY) is also focusing on building its intellectual property (IP) portfolio, including exclusive rights to at least 22 issued or pending patents. In wake of receiving FDA approval of its Epidiolex® (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, GW Pharmaceuticals Plc (NASDAQ: GWPH) has applied for five new Epidiolex patents. Recently Canopy Growth Corporation (NYSE: CGC) announced that it has, alone or with its subsidiary or joint-venture partners, filed eight provisional U.S. patents pertaining to the delivery and application of cannabis and cannabinoid-based therapeutics. And through its ownership of CanniMed, Aurora Cannabis, Inc. (OTCQX: ACBFF) has obtained…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Calgary Police Officers Barred from Consuming Cannabis Ahead of Legalization

Calgary police officers have been told they aren’t allowed to consume recreational cannabis just weeks before recreational marijuana hits the shelves of retail outlets. The news was communicated in an internal memo circulated to all police officers.

The ban excludes members of the police service who cannot be deployed or called to a scene of crime. These include desk officers or those whose work is entirely administrative.

The police top brass say this policy decision was taken as a precautionary measure to prevent any workplace safety issues that may arise. It isn’t known for how long someone can remain impaired after consuming cannabis.

The Calgary Police Service has expressed a desire to partner with an academic institution to conduct relevant research that will provide the concrete information needed to modify this blanket ban on the consumption of recreational cannabis. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTC: MCOA) would certainly appreciate any windows of regulatory change signaled by the authorities in their areas of operation.

The willingness by the police authority to modify the ban may come as a small piece of good news since police officers were wondering how they could be banned from lighting up a joint during an entire five-day break from duty.

The ban may also raise some fundamental rights issues. Can the Calgary Police Service dictate what its officers do when they are off duty?

A look at how the army has handled the same issue can shed more light on how unfair this policy may be. Members of the military are required to abstain from consuming cannabis within eight hours before reporting for duty. Can’t a similar provision be made for the police service?

That takes the police back to the limited information on how long cannabis can render someone impaired.

Understandably, the union of police officers isn’t happy about this policy, but they have little to do since they have been promised that the policy is likely to change as more information becomes available about how cannabis affects cognition, psychomotor function and other processes in the human body.

One of the sentences in the memo states that it can be hard for one to self-detect that he or she has had their cognitive abilities impaired by cannabis. The abstinence policy therefore remains a logical position until more research is done to understand the effects of cannabis.

It would be interesting to listen in to the conversations that may be taking place among the leaders of the law enforcement agencies in the U.S. states where recreational cannabis has been decriminalized. Would they also take the path of forced abstinence like the Calgary Police Service has decided?

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – UC San Diego Researchers to Study Effect of Cannabis on Essential Tremors

Researchers at the University College San Diego have announced their intention to investigate the effect of using cannabis extracts to treat or manage essential tremor.

The announcement came after the group of researchers (led by Dr. Fatta Nahab) got permission from the DEA (Drug Enforcement Administration) to import capsules of CBD and THC from Tilray, a Canadian-based cannabis company. Tilray conducted an initial public offering (IPO) in the U.S.

The researchers opted to import the capsules since none are available from the sole source of cannabis for research purposes (University of Mississippi). Capsules were preferred for this study because of two main reasons.

The first reason is that it would be easy for the researchers to control how much cannabis the study subjects received. This isn’t easy to do if the subjects smoke or vape the product.

Secondly, capsules were thought to be more acceptable to the study subjects who may have had issues with being asked to smoke or vaporize the cannabis.

The researchers had to jump through numerous hoops in order to get approval for the importation of the cannabis. For example, they had to submit the designs of the study to the research review panel of California as well as explain that the selected ratio of 20:1 CBD and THC was tailored to minimize the high and possible addiction by the patients who consumed the products during the study. The regulatory hurdles faced by the researchers are well known to companies like Lexaria Bioscience Corp (CSE: LXX) (OTC:LXRP) and Phivida Holdings Inc. (CSE: VIDA) (OTC:PHVAF), who have the eagle eye of regulators on everything they do.

The research team hopes to enroll 16 to 20 essential tremor patients to participate in this study that is expected to begin early next year and run for a year or more.

It is hoped that the study will provide scientific evidence for the anecdotal claims that essential tremor patients improved when they consumed cannabis. The researchers want to discover how much cannabis is sufficient to produce the desired results without triggering any adverse effects.

Such a cure would be a major breakthrough, since there is no medication designed for managing or treating essential tremor (ET). Patients are given high blood pressure medication or epilepsy drugs to manage this neurological disorder. The results of such interventions vary widely.

About 10 million Americans suffer from ET, and the condition is often mistaken for Parkinson’s disease. The International Essential Tremor Foundation and Tilray have funded the research. Tilray insists it will not have any say in the outcome of the study.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net